BioCentury
ARTICLE | Company News

f-star Biotechnologische Forschungs und Entwicklungs GmbH, Boehringer Ingelheim deal

December 6, 2010 8:00 AM UTC

f-star partnered with Boehringer to discover and develop antibody-derived therapeutics using f-star's Modular Antibody Technology. The companies will jointly discover products against up to seven targ...